Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    9022951 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Replacement GH Therapy After Bariatric Surgery in Patients With Very Severe Obesity
Conditions: Obesity;   GHD
Intervention: Drug: Recombinant GH Saizen (Merck-Serono)

Study has passed its completion date and status has not been verified in more than two years.